FDCDDQ
STAB

Federation des caisses Desjardins du Quebec’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio STAB Stock Details STAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-100
Closed -$197 – 2407
2020
Q3 		$197 Hold
100
– – ﹤0.01% 2121
2020
Q2 		$257 Hold
100
– – ﹤0.01% 2062
2020
Q1 		$166 Buy
+100
New +$204 ﹤0.01% 2170

Other funds holding STAB

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's STAB Position: Q4 2020 in Review

Federation des caisses Desjardins du Quebec sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q4 2020, closing a stake of 100 shares — an estimated $197 sold.

Federation des caisses Desjardins du Quebec first reported a position in STAB in Q1 2020 and held it in 3 quarters. The position peaked at $257 in Q2 2020. 21 funds tracked by Wall St. Rank hold STAB as of Q4 2020.

  • Federation des caisses Desjardins du Quebec reported no remaining Statera Biopharma, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 100 Statera Biopharma, Inc. Common Stock shares in Q4 2020, an estimated $197.
  • Federation des caisses Desjardins du Quebec first reported a position in Statera Biopharma, Inc. Common Stock in Q1 2020 and held it in 3 quarters.
  • Federation des caisses Desjardins du Quebec's Statera Biopharma, Inc. Common Stock position peaked at $257 in Q2 2020.
  • 21 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q4 2020.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q4 2020, filed 30 Aug 2024.